Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Anti-PD-1 Antibody +1 More for Solid Tumors
Recruiting1 awardPhase 1 & 2
Canton, Ohio
This trial is testing a new drug called LM-108, alone or with another drug, in patients with advanced solid tumors. The goal is to see if these drugs are safe and effective. The other drug helps the immune system fight cancer and has been approved for the treatment of various cancers since 2014.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service